Skip Nav Destination
Issues
15 July 2008
-
Cover Image
Cover Image
Two DU145 clones, with low and high junB expression, were transfected with GFP-encoding plasmids and plated on chick chorioallantoic membrane (CAM) to investigate the potential for invasion. After transfection, the clones were seeded atop the CAM of 11-day-old chicks and cultured for 3 or 5 days. More numerous macroscopic allantoic vessels radiating in a wheel pattern were seen toward the low junB clone than toward the high junB clone. CAM tissues were fixed and stained with anti-GFP and the invading cell numbers and the depth of invasion were quantified from the CAM surface. For more details, please see Konishi and coworkers on page 4408 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editor’s Note
Statistics in Clinical Cancer Research
Molecular Pathways
Report from the FDA
Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies
Robert J. Lechleider; Edvardas Kaminskas; Xiaoping Jiang; Robeena Aziz; Julie Bullock; Ravindra Kasliwal; Ravi Harapanhalli; Sarah Pope; Rajeshwari Sridhara; John Leighton; Brian Booth; Ramzi Dagher; Robert Justice; Richard Pazdur
Perspective
Reviews
Human Cancer Biology
Imaging, Diagnosis, Prognosis
Analysis and Reproducibility of 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer
Anthony F. Shields; Jawana M. Lawhorn-Crews; David A. Briston; Sajad Zalzala; Shirish Gadgeel; Kirk A. Douglas; Thomas J. Mangner; Lance K. Heilbrun; Otto Muzik
Cancer Therapy: Clinical
Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
Leigh Ellis; Yan Pan; Gordon K. Smyth; Daniel J. George; Chris McCormack; Roxanne Williams-Truax; Monica Mita; Joachim Beck; Howard Burris; Gail Ryan; Peter Atadja; Dale Butterfoss; Margaret Dugan; Kenneth Culver; Ricky W. Johnstone; H. Miles Prince
Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel
Carlos M. Galmarini; Isabelle Treilleux; Fatima Cardoso; Chantal Bernard-Marty; Virginie Durbecq; David Gancberg; Marie-Christine Bissery; Marianne Paesmans; Denis Larsimont; Martine J. Piccart; Angelo Di Leo; Charles Dumontet
A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
Lia Gore; Mace L. Rothenberg; Cindy L. O'Bryant; Mary Kay Schultz; Alan B. Sandler; Denise Coffin; Candice McCoy; Astrid Schott; Catherine Scholz; S. Gail Eckhardt
Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
Barbara G. Molenkamp; Berbel J.R. Sluijter; Paul A.M. van Leeuwen; Saskia J.A.M. Santegoets; Sybren Meijer; Pepijn G.J.T.B. Wijnands; John B.A.G. Haanen; Alfons J.M. van den Eertwegh; Rik J. Scheper; Tanja D. de Gruijl
ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel
Tristan M. Sissung; Caitlin E. Baum; John Deeken; Douglas K. Price; Jeanny Aragon-Ching; Seth M. Steinberg; William Dahut; Alex Sparreboom; William D. Figg
Cancer Therapy: Preclinical
Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
Karen Liby; Renee Risingsong; Darlene B. Royce; Charlotte R. Williams; Mark M. Yore; Tadashi Honda; Gordon W. Gribble; William W. Lamph; Nicola Vannini; Ilaria Sogno; Adriana Albini; Michael B. Sporn
Molecular Characterization of the Pediatric Preclinical Testing Panel
Geoffrey Neale; Xiaoping Su; Christopher L. Morton; Doris Phelps; Richard Gorlick; Richard B. Lock; C. Patrick Reynolds; John M. Maris; Henry S. Friedman; Jeffrey Dome; Joseph Khoury; Timothy J. Triche; Robert C. Seeger; Richard Gilbertson; Javed Khan; Malcolm A. Smith; Peter J. Houghton
A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway
Zohar Tiran; Anat Oren; Chen Hermesh; Galit Rotman; Zurit Levine; Hagit Amitai; Tal Handelsman; Merav Beiman; Aviva Chen; Dalit Landesman-Milo; Liat Dassa; Yair Peres; Cynthia Koifman; Sarit Glezer; Rinat Vidal-Finkelstein; Kobi Bahat; Tania Pergam; Cylia Israel; Judith Horev; Ilan Tsarfaty; Michal Ayalon-Soffer
Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models
Roberta Vitali; Camillo Mancini; Vincenzo Cesi; Barbara Tanno; Mariateresa Mancuso; Gianluca Bossi; Ying Zhang; Robert V. Martinez; Bruno Calabretta; Carlo Dominici; Giuseppe Raschellà
Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo
Nobuyuki Watanabe; Munenori Takaoka; Kazufumi Sakurama; Yasuko Tomono; Shinji Hatakeyama; Osamu Ohmori; Takayuki Motoki; Yasuhiro Shirakawa; Tomoki Yamatsuji; Minoru Haisa; Junji Matsuoka; David G. Beer; Hitoshi Nagatsuka; Noriaki Tanaka; Yoshio Naomoto
Cancer Prevention and Susceptibility
Penetrance Analysis of the PALB2 c.1592delT Founder Mutation
Hannele Erkko; James G. Dowty; Jenni Nikkilä; Kirsi Syrjäkoski; Arto Mannermaa; Katri Pylkäs; Melissa C. Southey; Kaija Holli; Anne Kallioniemi; Arja Jukkola-Vuorinen; Vesa Kataja; Veli-Matti Kosma; Bing Xia; David M. Livingston; Robert Winqvist; John L. Hopper
A Novel Breast Cancer–Associated BRIP1 (FANCJ/BACH1) Germ-line Mutation Impairs Protein Stability and Function
Arcangela De Nicolo; Mariella Tancredi; Grazia Lombardi; Cristina Chantal Flemma; Serena Barbuti; Claudio Di Cristofano; Bijan Sobhian; Generoso Bevilacqua; Ronny Drapkin; Maria Adelaide Caligo
Advertisement